AKAP13 and cardiac hypertrophy: Subsequent in vivo studies showed that gene-trap mice expressing a PKD1 binding deficient mutant of AKAP-Lbc were not able to sustain compensatory cardiac hypertrophy in response TAC or chronic treatment with hypertrophic agonists [28].